This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of liver and intrahepatic bile ducts
C3_LIVER_INTRAHEPATIC_BILE_DUCTS
liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1421 |
4. Check minimum number of eventsNone |
1421 |
5. Include endpointsNone |
1421 |
6. Filter based on genotype QC (FinnGen only) |
1258 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of liver and intrahepatic bile ducts
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1258 | 301 | 957 |
| Unadjusted period prevalence (%) | 0.36 | 0.11 | 0.44 |
| Median age at first event (years) | 72.36 | 72.02 | 72.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1304
- Matched controls
- 13040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z51.5
ICD-10 Finland
Palliative care
26.4
307.7
552
353
N02AA05
ATC
oxycodone; systemic
8.8
307.7
640
1286
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
164.2
307.7
445
41
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
627
*
JN4CD
NOMESCO Finland
Very extensive body CT
37.5
307.7
206
65
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
36.9
307.7
242
80
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
12.1
307.7
417
486
A03FA01
ATC
metoclopramide; systemic, rectal
12.8
307.7
536
673
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
677
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
900
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
219.2
307.7
466
33
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
3665.5
307.7
299
*
H02AB02
ATC
dexamethasone; systemic
38.5
307.7
211
65
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
287.4
265
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
27.0
282.6
200
87
R18
ICD-10 Finland
Ascites
28.2
269.4
187
77
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
38.7
265.9
166
49
JN4AD
NOMESCO Finland
Body CT examination
10.0
256.7
340
444
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
251.4
233
*
198
Kela drug reimbursment
Sorafenib
+∞
240.2
223
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
232.4
216
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
32.0
224.4
148
52
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
27.8
220.9
153
62
A04AA01
ATC
ondansetron; systemic, rectal
22.1
219.3
167
86
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.3
196.7
159
93
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
26.3
194.3
137
58
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.4
187.7
160
104
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.8
180.0
176
146
JN4BD
NOMESCO Finland
Extensive body CT
9.7
178.5
227
276
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
166.3
156
*
A04AA02
ATC
granisetron; systemic, transdermal
582.7
159.5
155
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.7
158.5
370
852
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
13.7
156.6
152
124
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.4
137.2
220
348
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
134.8
127
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
64.4
132.0
73
12
L01XE05
ATC
[U] sorafenib
+∞
128.3
121
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1343.5
127.3
122
*
323
Kela drug reimbursment
Sorafenib
+∞
127.2
120
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
126.9
552
2022
127
Kela drug reimbursment
Transplant complication
22.2
121.7
91
44
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
31.8
119.3
78
26
JN3AD
NOMESCO Finland
Abdominal CT examination
4.9
118.7
317
803
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
1199.0
114.4
110
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
400.5
112.2
111
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
111.0
105
*
K83.1
ICD-10 Finland
Obstruction of bile duct
20.8
109.5
84
43
C03DA01
ATC
spironolactone; oral
4.0
107.6
408
1337
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
16.6
105.2
90
58
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
16.9
102.6
87
55
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
520.9
98.9
97
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
97.1
92
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
56.3
95.2
54
10
K83.0
ICD-10 Finland
Cholangitis
12.8
91.7
91
76
L01BC06
ATC
capecitabine; oral
+∞
90.7
86
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
89.0
567
2533
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
33.1
88.3
57
18
L04AD02
ATC
tacrolimus; systemic
23.2
87.6
64
29
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
48.2
87.1
51
11
L04AA06
ATC
mycophenolic acid; systemic
13.3
87.0
84
67
WW500
NOMESCO Finland
Blood transfusion
10.1
86.1
101
108
A07AA11
ATC
rifaximin; oral
50.9
84.6
49
10
Z94.4
ICD-10 Finland
Liver transplant status
136.3
84.1
89
7
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
26.3
83.4
58
23
L01EX02
ATC
sorafenib; oral
+∞
83.2
79
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
80.0
76
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
39.1
79.6
49
13
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
78.6
144
257
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
24.3
78.2
56
24
WF002
NOMESCO Finland
Radical radiotherapy
110.7
76.9
83
8
A05AA02
ATC
ursodeoxycholic acid; oral
16.6
76.5
65
41
JJC00
NOMESCO Finland
Allogenic transplantation of liver
198.7
72.9
75
*
3019
Kela drug reimbursment
Lenvatinib
+∞
72.6
69
*
A06AH03
ATC
naloxegol; oral
24.1
71.0
51
22
WF049
NOMESCO Finland
Radiotherapy of metastasis
726.2
70.8
69
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
726.2
70.8
69
*
UJK02
NOMESCO Finland
ERCP
7.8
70.7
101
138
1508
Kela drug reimbursment
Lenvatinib
+∞
70.5
67
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
16.4
67.8
58
37
D77
ICPC
Malignant digestive neopl other/NOS
349.5
67.2
67
*
WZC30
NOMESCO Finland
Teaching
3.6
65.5
261
858
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
22.6
65.2
48
22
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
11.7
64.4
67
60
A06AD11
ATC
lactulose; oral
3.0
63.2
367
1509
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
62.0
59
*
L01EX08
ATC
lenvatinib; oral
+∞
62.0
59
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
59.9
590
3161
116
Kela drug reimbursment
Prostate cancer
+∞
59.9
57
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.5
59.8
122
240
I81
ICD-10 Finland
Portal vein thrombosis
25.5
59.7
42
17
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
58.8
190
540
K76.9
ICD-10 Finland
Liver disease, unspecified
12.6
58.5
58
48
C03CA01
ATC
furosemide; systemic
2.5
55.9
686
4033
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
198.5
55.4
57
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
7.7
55.1
79
108
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
53.5
51
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
53.0
667
3935
B01AB10
ATC
tinzaparin; parenteral
3.8
51.7
176
517
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
51.4
49
*
A10BA02
ATC
metformin; oral
2.4
50.5
583
3293
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
48.2
528
2900
A10AE04
ATC
insulin glargine; parenteral
3.1
47.8
239
891
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
484.9
47.6
47
*
176
Kela drug reimbursment
Regorafenib
+∞
47.2
45
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
47.2
45
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
46.8
248
955
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.6
45.2
41
29
L03AA02
ATC
filgrastim; parenteral
124.5
45.1
48
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
44.0
42
*
L04AD01
ATC
ciclosporin; systemic
9.8
43.5
51
54
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
43.5
460
2466
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
64.9
43.5
50
8
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.1
42.9
49
50
A10AB05
ATC
insulin aspart; parenteral
3.3
42.9
185
630
K92.0
ICD-10 Finland
Haematemesis
5.2
42.5
91
186
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
42.4
217
816
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
41.8
355
1722
N02AA01
ATC
morphine; systemic, rectal
7.3
40.9
61
87
ZX120
NOMESCO Finland
Intravenous
3.6
40.0
145
442
B01AB05
ATC
enoxaparin; parenteral
2.3
39.7
429
2304
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
15.0
39.2
35
24
R50.9
ICD-10 Finland
Fever, unspecified
2.7
38.7
252
1074
A79
ICPC
Malignancy NOS
105.8
37.9
41
*
369
Kela drug reimbursment
Regorafenib
+∞
37.7
36
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
37.6
707
4689
J01MA12
ATC
levofloxacin; systemic
2.4
37.0
318
1541
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
36.6
35
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
55.5
36.6
43
8
T90
ICPC
Diabetes non-insulin dependent
2.2
35.6
455
2594
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
35.6
34
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
52.8
34.6
41
8
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.5
34.5
50
69
WX402
NOMESCO Finland
General anaesthesia
2.5
33.8
263
1214
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
33.5
32
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
33.5
32
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
335.3
33.0
33
*
A10BB12
ATC
glimepiride; oral
2.7
33.0
199
811
L03AA13
ATC
pegfilgrastim; parenteral
174.4
32.9
34
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
119.8
32.8
35
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.9
32.8
60
106
UJF32
NOMESCO Finland
Coloscopy
2.2
32.7
381
2083
R4110
NOMESCO Finland
Physiotherapy
2.2
32.5
388
2141
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
32.4
31
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
324.7
32.0
32
*
L01EX05
ATC
regorafenib; oral
+∞
31.4
30
*
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
31.4
30
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
61.6
31.2
36
6
JJB30
NOMESCO Finland
Excision of two segments of liver
320.3
31.0
31
*
A02BC02
ATC
pantoprazole; systemic
2.0
30.8
878
6565
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.9
30.4
55
96
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
30.3
29
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
30.3
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
30.3
317
1654
L02AE02
ATC
leuprorelin; implant, parenteral
59.9
30.2
35
6
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
309.3
29.9
30
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
29.3
28
*
B01AB04
ATC
dalteparin; parenteral
3.9
29.0
89
241
JJA20
NOMESCO Finland
Open biopsy of liver
105.8
28.8
31
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
30.1
28.6
38
13
160
Kela drug reimbursment
exenatide
5.4
28.3
57
110
TJA10
NOMESCO Finland
Laparocentesis
102.3
27.8
30
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
27.2
26
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
27.2
26
*
R4190
NOMESCO Finland
Nutritional therapy
5.3
27.1
55
107
SPAT1262
SPAT
Handing over of treatment supplies
2.1
26.8
299
1592
JAH00
NOMESCO Finland
Laparotomy
4.9
26.4
59
125
WW200, ,
SPAT
0.4
26.2
112
2751
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
74.2
25.9
29
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
265.7
25.8
26
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
265.7
25.8
26
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
265.7
25.8
26
*
TK800
NOMESCO Finland
Hemodialysis
5.2
25.6
53
105
A10BX07
ATC
[U] liraglutide
6.4
25.4
42
67
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
25.1
52
103
115
Kela drug reimbursment
Breast cancer
+∞
25.1
24
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
25.1
24
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
25.1
24
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
25.0
202
939
A10BH01
ATC
sitagliptin; oral
2.4
25.0
195
893
D97
ICPC
Liver disease NOS
21.7
24.8
36
17
K92.1
ICD-10 Finland
Melaena
2.9
24.5
120
436
A10AE05
ATC
insulin detemir; parenteral
3.0
24.5
113
397
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
24.0
23
*
L02BB03
ATC
bicalutamide; oral
+∞
24.0
23
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
24.0
23
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
244.3
23.7
24
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
244.3
23.7
24
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
244.3
23.7
24
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
25.2
23.1
32
13
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
23.0
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
22.7
304
1720
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.0
22.4
282
1560
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
5.4
22.1
44
84
XW000
NOMESCO Finland
Bone marrow biopsy
4.1
22.1
61
153
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
22.0
80
243
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
21.9
21
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
21.9
21
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
21.9
21
*
K72.1
ICD-10 Finland
Chronic hepatic failure
44.1
21.5
26
6
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
21.4
230
1198
J01MA02
ATC
ciprofloxacin; systemic
1.8
21.3
541
3732
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
21.1
70
200
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
20.8
77
237
JJ5AT, ,
NOMESCO Finland
213.3
20.6
21
*
A41.8
ICD-10 Finland
Other specified sepsis
4.3
20.6
53
126
A10AC01
ATC
insulin (human); parenteral
2.3
19.9
159
733
C07AG02
ATC
carvedilol; oral
2.5
19.7
130
550
WF003
NOMESCO Finland
Adjuvant radiotherapy
203.0
19.6
20
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
203.0
19.6
20
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
19.1
106
411
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
20.4
19.1
28
14
JKA20
NOMESCO Finland
Cholecystectomy
3.5
19.0
65
190
N05CF01
ATC
zopiclone; oral
1.8
18.9
441
2946
A10BG03
ATC
pioglitazone; oral
3.5
18.8
65
191
A10BX04
ATC
[U] exenatide
6.7
18.8
30
46
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
18.8
18
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
18.8
18
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
192.7
18.6
19
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
18.6
87
2097
162
Kela drug reimbursment
liraglutide
5.6
18.4
35
64
K72.9
ICD-10 Finland
Hepatic failure, unspecified
7.9
18.3
25
32
205
Kela drug reimbursment
Chronic hypertension
1.7
17.9
498
3479
Y77
ICPC
Malignant neoplasm prostate
67.6
17.8
20
*
L01XE21
ATC
[U] regorafenib
+∞
17.7
17
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
17.7
17
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
17.7
17
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
17.7
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.7
17
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.7
17
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
17.6
100
392
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
182.4
17.6
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
17.5
201
1068
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
15.0
17.2
28
19
WPB10
NOMESCO Finland
Making a convalescent care decision
31.9
17.1
22
7
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.5
17.0
29
22
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.9
16.9
50
132
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
16.7
196
1048
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
16.7
16
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
16.7
16
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
16.6
155
761
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.4
16.6
60
182
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
16.3
91
354
RS220, ,
NOMESCO Finland
6.6
16.2
26
40
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.2
16.1
24
34
SPAT1109
SPAT
Analgesia with portable analgesic pump
17.0
16.1
25
15
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
17.0
16.1
25
15
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
16.1
230
1316
SPAT1255
SPAT
Intravenous administration of medicine
2.5
15.8
108
463
JAH01
NOMESCO Finland
Laparoscopy
3.9
15.8
46
120
UJK12
NOMESCO Finland
Peroral cholangioscopy
33.8
15.8
20
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
33.8
15.8
20
6
XX4BW, ,
NOMESCO Finland
33.8
15.8
20
6
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
15.7
15
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
15.7
15
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
15.7
15
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
161.9
15.5
16
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
161.9
15.5
16
*
C07AA05
ATC
propranolol; systemic
1.9
15.5
212
1195
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.8
15.5
35
75
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
15.3
393
2665
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
15.3
138
668
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
18.6
14.7
22
12
D70.82
ICD-10 Finland
Drug-induced neutropenia
25.3
14.7
20
8
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
14.6
14
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
14.6
14
*
Z2446
NOMESCO Finland
Social worker
2.6
14.6
84
332
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.5
14.5
35
79
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
151.6
14.5
15
*
ZXE00
NOMESCO Finland
One hour or less
1.6
14.4
434
3057
L04AX01
ATC
azathioprine; systemic
3.1
14.2
59
195
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
14.1
72
267
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
13.9
441
3140
N06DX01
ATC
memantine; oral
0.3
13.9
30
1087
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
53.9
13.8
16
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
53.9
13.8
16
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
13.8
391
2708
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.6
13.8
26
25
K70.0
ICD-10 Finland
Alcoholic fatty liver
5.8
13.7
25
44
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
13.6
64
227
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
13.6
13
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
13.6
13
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
13.6
13
*
XX2RW, ,
NOMESCO Finland
11.1
13.5
25
23
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
13.5
86
357
C10AX09
ATC
ezetimibe; oral
0.4
13.4
75
1699
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
18.4
13.4
20
11
K70.4
ICD-10 Finland
Alcoholic hepatic failure
11.6
13.3
24
21
M04AA01
ATC
allopurinol; systemic
1.8
13.2
242
1488
R10.0
ICD-10 Finland
Acute abdomen
3.3
12.8
47
144
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
12.8
77
311
A10BH05
ATC
linagliptin; oral
2.3
12.7
101
463
HAC20
NOMESCO Finland
Total mastectomy
70.6
12.6
14
*
WX002
NOMESCO Finland
Sedation and analgesia
1.7
12.5
237
1470
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
12.5
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.5
12
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
12.5
12
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
12.5
12
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
12.5
12
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
12.5
12
*
L01XE29
ATC
[U] lenvatinib
+∞
12.5
12
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
24.6
12.5
17
7
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.6
12.5
17
7
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.2
12.5
50
162
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
12.4
31
72
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
13.3
12.4
21
16
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
12.4
123
616
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
12.4
69
268
A10BB01
ATC
glibenclamide; oral
2.2
12.4
112
542
Z2221
NOMESCO Finland
Medical doctor
1.7
12.3
292
1927
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
12.2
151
820
Z3231
NOMESCO Finland
Registered nurse
1.6
12.1
314
2115
H02AB06
ATC
prednisolone; systemic
1.5
12.0
570
4407
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.3
12.0
31
74
C10AA07
ATC
rosuvastatin; oral
0.6
12.0
204
3191
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
47.1
11.9
14
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.9
168
954
XQ902
NOMESCO Finland
Other photography
5.4
11.8
23
43
WX892
NOMESCO Finland
Monitored bed care
2.1
11.7
115
574
B03XA02
ATC
darbepoetin alfa; parenteral
4.0
11.6
33
85
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
11.2
11.6
21
19
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
11.5
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
11.5
11
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
121.0
11.4
12
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
11.3
116
589
C10AA05
ATC
atorvastatin; oral
0.6
11.1
362
4871
WPA13
NOMESCO Finland
Palliative consultation
14.0
11.0
18
13
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
11.0
65
261
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
11.0
98
472
A10BJ02
ATC
liraglutide; parenteral
3.1
10.8
45
149
EB1VA, ,
NOMESCO Finland
0.4
10.8
44
1153
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
10.8
121
634
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.9
10.8
49
171
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
10.7
237
3492
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
28.3
10.7
14
5
WVA20
NOMESCO Finland
Medicine administration
3.2
10.6
42
135
L04AA10
ATC
[U] sirolimus
60.5
10.6
12
*
A98
ICPC
Health maint/preventive medicine
0.7
10.6
904
10110
K29.6
ICD-10 Finland
Other gastritis
4.4
10.5
26
60
HA1AA
NOMESCO Finland
X-ray mammography
3.7
10.5
32
87
ZX070
NOMESCO Finland
Intensity modified radiotherapy
110.9
10.4
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
10.4
10
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
10.4
10
*
K75.0
ICD-10 Finland
Abscess of liver
16.2
10.4
16
10
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
10.7
10.3
19
18
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
10.2
25
849
ZXC40
NOMESCO Finland
Use of ultrasound
13.2
10.2
17
13
ZX108
NOMESCO Finland
Inhalation
8.0
10.1
22
28
A10BD07
ATC
metformin and sitagliptin; systemic
2.3
9.9
74
331
K76.7
ICD-10 Finland
Hepatorenal syndrome
16.8
9.9
15
9
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.7
9.8
53
203
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
4.4
9.8
24
55
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
9.6
9.8
19
20
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
9.7
191
1192
J01FF01
ATC
clindamycin; systemic
1.6
9.7
308
2164
P20
ICPC
Memory disturbance
0.5
9.7
97
1788
D69.5
ICD-10 Finland
Secondary thrombocytopenia
55.4
9.7
11
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
9.6
55
217
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.7
9.6
30
83
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
9.6
81
382
ZZR00
NOMESCO Finland
Flap of skin
9.2
9.5
19
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.5
342
2470
I85
ICD-10 Finland
Oesophageal varices
100.7
9.4
10
*
ZZA00
NOMESCO Finland
Split skin graft
3.1
9.4
38
124
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
30.2
9.4
12
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
30.2
9.4
12
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
L04AH02
ATC
everolimus; oral
+∞
9.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
9.4
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
21.9
9.4
13
6
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
21.9
9.4
13
6
L02BG04
ATC
letrozole; oral
21.9
9.4
13
6
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
9.3
34
104
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.9
9.3
20
41
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.1
9.3
25
62
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.4
9.1
59
248
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.6
9.1
21
46
J94.8
ICD-10 Finland
Other specified pleural conditions
3.4
9.1
32
96
K76.89
ICD-10 Finland
Other specified diseases of liver
15.7
9.0
14
9
G93.4
ICD-10 Finland
Encephalopathy, unspecified
9.1
9.0
18
20
WPA43, ,
SPAT
37.0
9.0
11
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
37.0
9.0
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
37.0
9.0
11
*
EB4VA, ,
NOMESCO Finland
0.3
9.0
27
821
A07AA09
ATC
vancomycin; oral
3.9
9.0
26
68
E0000UV, ,
ATC
1.5
9.0
440
3374
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
7.5
8.9
20
27
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
18.7
8.9
13
7
WX882
NOMESCO Finland
High dependency care
2.8
8.9
43
156
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
8.8
52
209
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
10.8
8.8
16
15
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
9.6
8.8
17
18
N05AX08
ATC
risperidone; systemic
0.4
8.7
36
937
ZXD05
NOMESCO Finland
Urgent procedure
1.5
8.6
352
2601
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
8.6
63
280
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
10.1
8.5
16
16
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.4
8.5
21
33
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.9
8.5
38
132
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
7.4
8.5
19
26
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
90.6
8.4
9
*
L04AA18
ATC
[U] everolimus
90.6
8.4
9
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
90.6
8.4
9
*
L02BA01
ATC
tamoxifen; oral
90.6
8.4
9
*
V03AE01
ATC
polystyrene sulfonate; oral
3.5
8.4
28
81
A10BD03
ATC
metformin and rosiglitazone; systemic
3.0
8.4
36
122
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.5
8.4
20
45
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.8
8.4
20
30
C09BA02
ATC
enalapril and diuretics; systemic
1.8
8.4
134
789
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.3
8
*
YJ3VG
NOMESCO Finland
MRI examination of abdomen with high intesity magnet for dose design of radiotherapy
+∞
8.3
8
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
8.3
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.3
8
*
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
8.3
8
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
8.3
61
271
K29.7
ICD-10 Finland
Gastritis, unspecified
2.5
8.3
53
221
SPAT1088
SPAT
Blood transfusion
10.8
8.3
15
14
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
8.3
82
412
N06DA02
ATC
donepezil; oral
0.3
8.2
28
800
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.6
8.2
117
1950
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
8.2
383
2900
JN6AD
NOMESCO Finland
CT of torso and neck
7.6
8.2
18
24
A10BG02
ATC
rosiglitazone; oral
3.1
8.2
33
108
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
8.1
97
520
N02AA03
ATC
hydromorphone; systemic, rectal
33.6
8.1
10
*
WZC15, ,
NOMESCO Finland
33.6
8.1
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
17.3
8.1
12
7
WPA44
NOMESCO Finland
Nursing home for palliative care
17.3
8.1
12
7
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.4
8.0
55
237
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
8.0
87
451
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
22.2
8.0
11
5
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
7.9
51
214
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
7.9
82
419
Z3226
NOMESCO Finland
Physiotherapist
1.6
7.9
200
1330
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.9
118
1940
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.9
7.8
35
122
WZC00, ,
SPAT
0.4
7.8
52
1107
H02AB04
ATC
methylprednisolone; systemic
1.6
7.7
170
1091
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
6.4
7.7
19
30
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
7.7
121
1965
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
7.6
89
474
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
7.6
71
349
R11
ICD-10 Finland
Nausea and vomiting
1.9
7.6
94
511
XF612
NOMESCO Finland
Measurement of central venous pressure
25.2
7.6
10
*
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
25.2
7.6
10
*
WPA11
NOMESCO Finland
Developing a plan for palliative care
25.2
7.6
10
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.2
7.6
29
92
B02AA02
ATC
tranexamic acid; systemic
1.9
7.5
98
541
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.8
7.5
37
136
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
7.5
93
1612
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
80.5
7.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
80.5
7.4
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
80.5
7.4
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
80.5
7.4
8
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
8.4
7.3
15
18
TDA90, ,
SPAT
0.3
7.3
17
592
K51.5
ICD-10 Finland
Left sided colitis
3.0
7.3
32
110
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.5
7.3
43
173
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
10.9
7.3
13
12
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
7.3
123
735
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
SPAT1122
SPAT
Ascites puncture
+∞
7.3
7
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.3
7
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
7.3
7
*
L02AE04
ATC
triptorelin; parenteral
+∞
7.3
7
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.3
7.3
27
84
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.5
7.2
17
38
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.0
7.2
20
51
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
7.2
73
371
TPX15
NOMESCO Finland
Removal of vascular injection port
20.1
7.1
10
5
B01AF01
ATC
rivaroxaban; oral
0.5
7.1
62
1202
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.7
7.1
38
146
UJD02
NOMESCO Finland
Gastroscopy
2.1
7.1
67
331
K74.0
ICD-10 Finland
Hepatic fibrosis
12.1
7.1
12
10
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
12.1
7.1
12
10
A07AA02
ATC
nystatin; oral
2.1
7.1
69
345
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
7.1
106
1745
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
7.0
93
517
C10AC01
ATC
colestyramine; oral
2.9
7.0
32
113
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.9
6.9
18
31
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
6.9
267
3560
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
6.9
94
1589
M05BX04
ATC
denosumab; parenteral
2.2
6.8
55
255
D05AX52
ATC
calcipotriol, combinations; topical
2.1
6.8
63
309
JCA20
NOMESCO Finland
Ligature of oesophageal varices
40.3
6.8
8
*
WPA43
NOMESCO Finland
A doctor's home visit to perform palliative care
40.3
6.8
8
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
40.3
6.8
8
*
I86.4
ICD-10 Finland
Gastric varices
16.8
6.7
10
6
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
6.7
56
263
K76.6
ICD-10 Finland
Portal hypertension
22.6
6.7
9
*
A10BJ01
ATC
exenatide; parenteral
4.0
6.6
18
45
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.5
6.6
18
33
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.6
6.6
117
1846
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.2
6.6
51
233
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
10.1
6.5
12
12
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.5
96
552
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.5
255
1860
D02AE01
ATC
carbamide; topical
2.0
6.5
71
371
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
0.1
6.4
*
220
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
70.2
6.4
7
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.4
6.4
14
19
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
14.4
6.4
10
7
J01DB01
ATC
cefalexin; oral
1.4
6.4
907
8138
R4110, ,
SPAT
0.5
6.3
50
1002
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.3
6.3
23
71
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
6.3
70
368
8010/3-C22.1
ICD-O-3
Carcinoma, NOS, of intrahepatic bile duct
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
TQW20
NOMESCO Finland
Tatoe
+∞
6.3
6
*
9120/3-C22.0
ICD-O-3
Hemangiosarcoma of liver
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
6.3
6
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
L01BC04
ATC
carmofur; oral
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
6.3
6
*
8180/3-C22.0
ICD-O-3
Combined hepatocellular carcinoma and cholangiocarcinoma of liver
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
6.2
18
557
A10BB07
ATC
glipizide; oral
2.6
6.2
34
132
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
26.8
6.2
8
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
26.8
6.2
8
*
K50.8
ICD-10 Finland
Other Crohn disease
4.0
6.2
17
43
A07EA02
ATC
hydrocortisone; rectal
3.1
6.1
24
78
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.3
6.1
13
472
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
10.1
6.0
11
11
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.0
833
7408
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
724
546
28.56
307.65
4.6
1.4
22.56
2.88
ug/l
1.41
633
409
344
260
17.61
307.65
5.4
2.7
44.18
38.85
umol/l
0.74
327
237
489
196
39.32
307.65
4.4
2.0
722.61
38.50
u/ml
3.05
446
158
561
847
10.87
307.65
6.0
2.1
0.17
0.19
g/l
6.80
534
770
306
119
33.29
307.65
3.9
1.7
343.25
40.28
u/ml
2.69
285
108
280
240
14.58
284.40
1.5
1.2
55.56
96.84
titre
1.25
18
19
517
1042
7.56
267.22
12.2
2.3
22.27
9.09
umol/l
7.03
495
917
204
118
20.31
255.01
1.3
1.1
1.65
1.58
g/l
0.93
195
107
110
11
109.12
214.07
4.6
2.5
1339.37
6.18
ug/l
1.74
110
11
429
1116
5.24
159.66
13.0
6.6
8.84
11.43
mmol/l
8.97
415
1054
94
36
28.06
137.58
2.3
2.4
956.72
571.48
e6/l
0.60
67
27
119
81
16.07
135.57
1.6
1.2
—
—
—
0
0
615
2454
3.85
124.07
16.7
3.9
74.63
81.25
%
9.06
600
2401
78
24
34.50
122.24
4.5
2.4
0.58
0.60
mmol/l
0.75
78
24
885
4586
3.89
117.82
17.3
4.0
31.36
34.98
g/l
55.37
852
4229
80
30
28.34
117.73
2.3
2.1
1487.91
68901.24
e6/l
0.55
45
17
246
505
5.77
117.42
1.6
1.3
1.34
1.17
g/l
0.96
219
470
934
5029
4.02
117.00
28.2
4.1
25.41
13.05
umol/l
14.34
914
4753
684
3045
3.62
114.46
13.4
2.7
65.04
42.23
u/l
2.87
667
2840
129
144
9.83
106.91
9.5
5.6
886.26
389.05
iu/ml
0.85
42
20
148
199
8.26
105.77
1.2
1.3
—
—
—
0
0
262
626
4.99
104.51
2.2
2.1
13.25
11.11
g/l
6.80
238
581
89
57
16.68
104.33
2.3
2.2
40.85
65.99
iu/ml
—
11
8
678
3155
3.39
102.72
6.0
2.4
55.47
61.42
u/l
1.76
655
2902
456
1670
3.66
101.20
6.6
2.7
0.76
0.82
mmol/l
22.03
440
1540
324
942
4.25
100.30
2.5
1.7
1.66
1.62
%
0.48
288
801
351
1151
3.80
90.85
4.0
2.1
250.56
234.05
u/l
1.65
343
1067
91
79
12.31
89.49
1.3
1.4
162.00
185.00
titre
0.07
15
14
293
865
4.08
87.92
4.6
2.2
34.72
40.80
u/l
0.48
253
696
110
129
9.22
87.53
1.4
1.3
143.72
152.88
au/ml
0.23
25
46
417
1635
3.28
80.39
3.0
2.8
23.74
22.54
%
0.75
408
1506
107
138
8.36
78.78
1.4
1.2
330.94
275.34
u/ml
0.69
72
70
897
5440
3.08
77.63
24.1
20.6
1.29
1.40
inr
10.83
794
4601
112
156
7.76
77.23
1.5
1.3
—
23.32
—
0
5
149
280
5.88
77.07
8.3
3.6
1.67
1.77
mg/l
0.64
138
238
58
31
19.53
73.88
1.8
1.4
9.74
12.40
g/l
0.77
45
21
419
1772
3.01
69.43
3.0
2.7
2.27
2.22
g/l
0.76
397
1622
56
33
17.69
68.11
34.3
31.5
137.05
138.49
ug/l
0.03
44
28
67
56
12.56
67.27
1.2
1.1
—
—
—
0
0
488
2289
2.81
66.16
4.5
2.2
—
—
—
0
0
86
109
8.38
64.07
3.4
2.8
164.50
269.57
u/ml
—
8
14
407
1767
2.89
63.47
3.8
1.9
32.12
29.95
s
6.64
401
1720
425
1898
2.84
62.74
3.1
2.7
12.68
12.34
umol/l
0.41
406
1743
727
4305
2.56
59.53
5.3
2.5
—
—
estimate
—
0
0
44
21
21.65
58.69
1.1
1.0
—
—
—
0
0
55
42
13.63
58.22
1.7
1.4
—
—
—
0
0
157
397
4.36
56.88
3.0
1.5
0.17
0.34
mg/l
4.67
55
181
816
5241
2.49
53.97
19.4
6.0
4.33
4.51
e9/l
1.11
738
4440
59
59
10.43
52.53
1.3
1.3
90.25
80.20
—
6
5
333
1479
2.68
47.98
9.3
5.5
1.07
1.03
mmol/l
1.27
314
1361
120
304
4.25
43.09
2.0
1.7
—
—
—
0
0
58
74
8.16
42.83
1.0
1.0
283.69
284.01
mg/l
0.01
51
68
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
138
396
3.78
41.68
4.4
2.8
0.28
0.34
iu/ml
1.43
72
225
258
1112
2.65
38.70
11.4
7.2
1.67
1.47
mmol/l
1.46
250
1086
833
5864
2.16
38.04
13.6
3.2
222.80
53.47
u/l
51.61
802
5384
711
4845
2.03
33.76
12.0
6.0
1.19
1.20
mmol/l
3.61
688
4394
197
791
2.76
33.69
13.6
9.4
94.58
93.48
%
2.03
197
786
767
5380
2.03
33.45
12.2
6.2
1.19
1.21
mmol/l
4.10
671
4606
145
503
3.12
32.29
2.2
1.7
1.64
2.04
ug/l
0.36
136
436
184
730
2.77
32.13
1.9
1.6
—
—
—
0
0
34
31
11.23
32.09
2.0
1.6
2365288.57
1930639.80
iu/ml
—
7
5
174
677
2.81
31.51
14.2
9.6
15.37
15.92
%
1.58
166
659
291
1454
2.29
30.98
11.5
7.2
12.35
11.17
kpa
4.51
276
1396
290
1454
2.28
30.58
11.5
7.2
4.95
5.07
kpa
1.52
275
1396
269
1310
2.33
30.36
12.0
7.3
96.40
94.78
%
5.02
260
1266
851
6326
1.99
29.90
13.5
5.0
7.58
6.94
mmol/l
9.66
829
6026
286
1453
2.24
29.07
11.5
7.2
0.17
1.12
mmol/l
3.54
236
1195
249
1202
2.32
28.54
12.6
7.7
115.73
122.16
g/l
5.06
241
1182
266
1333
2.25
27.84
6.1
3.5
1.18
1.86
mmol/l
2.39
209
1150
35
41
8.74
27.60
1.5
1.3
—
—
—
0
0
181
770
2.57
27.31
14.5
9.5
0.60
0.64
%
0.84
181
765
950
7501
1.98
25.99
30.8
5.7
173.78
78.74
u/l
61.80
924
7004
45
76
6.10
25.71
1.0
1.0
—
—
—
0
0
182
802
2.48
25.42
14.4
9.2
1.38
1.30
%
0.83
182
797
505
3297
1.87
24.85
7.3
2.1
2.33
2.34
mmol/l
1.73
480
2874
354
2059
1.99
24.67
6.8
2.2
2.51
2.45
mmol/l
13.61
335
1804
470
3010
1.88
24.50
4.3
3.2
1.01
0.48
e6/l
2.18
373
2228
290
1578
2.08
24.28
1.8
1.3
4.08
2.88
g/l
9.43
231
902
223
1106
2.23
23.64
4.4
3.4
—
—
—
0
0
230
4073
0.47
23.63
2.7
1.9
1.67
1.30
mmol/l
5.77
207
3361
165
726
2.46
23.03
14.8
9.2
23.62
24.15
mmol/l
1.25
160
705
306
1734
2.00
22.74
3.5
3.1
1.29
1.52
e6/l
0.47
178
866
343
2060
1.90
21.30
2.3
1.9
—
—
—
0
0
51
115
4.57
21.16
4.1
2.5
1.60
1.27
%
0.23
45
93
175
844
2.24
19.67
4.4
2.3
64.13
62.32
ml/min/173m2
0.18
83
349
514
3556
1.74
19.63
4.5
3.3
62.38
89.08
e6/l
0.46
421
2747
316
1896
1.88
19.45
3.3
3.0
0.92
1.08
e6/l
0.48
189
1034
443
2967
1.75
18.81
3.2
2.4
3.73
2.82
mg/l
8.80
389
2511
257
1462
1.94
18.50
2.2
1.9
—
—
—
0
0
266
1577
1.86
16.73
2.3
1.9
—
—
—
0
0
51
138
3.81
16.67
1.1
1.3
—
—
—
0
0
37
78
4.85
16.66
1.0
1.2
45.22
46.46
u/l
0.08
32
67
38
82
4.74
16.64
1.7
1.5
16.28
23.56
ng/l
2.34
38
82
75
269
2.90
15.64
1.3
1.5
250.00
285.26
ug/g
0.69
44
174
537
3926
1.63
15.63
5.1
3.9
62.54
113.90
e6/l
1.59
431
2837
803
6559
1.58
14.01
5.4
4.7
1004.13
2789.46
e6/l
0.78
16
130
54
171
3.25
13.95
7.2
6.2
11.27
12.47
mg/l
0.73
47
158
19
8
24.07
13.80
1.6
1.0
—
—
—
0
0
153
805
2.02
13.56
5.4
3.1
1.21
1.22
mmol/l
1.11
141
677
365
2496
1.64
13.49
3.8
2.5
5.66
4.70
e6/l
0.77
347
2269
813
9388
0.64
12.53
6.2
5.6
4.14
4.32
mmol/l
5.27
732
8646
157
857
1.95
12.50
3.4
1.8
421.18
372.49
nmol/l
1.87
148
776
24
45
5.41
12.32
2.8
1.5
—
—
—
0
0
63
235
2.77
12.25
5.0
4.5
2.04
2.62
mmol/l
1.16
39
155
807
9309
0.65
12.04
6.1
5.5
1.24
1.38
mmol/l
17.82
719
8503
344
4715
0.63
11.64
3.7
4.1
21.92
24.38
%
2.03
156
2357
843
9616
0.65
11.64
6.5
6.5
2.38
2.48
mmol/l
2.66
754
8834
122
631
2.03
11.31
1.6
1.5
—
—
—
0
0
24
49
4.97
11.23
1.6
1.4
5.76
6.48
u/l
0.07
17
41
168
970
1.84
11.23
2.0
1.6
65.65
66.28
g/l
0.40
149
875
61
238
2.64
10.90
1.9
1.4
—
—
—
0
0
395
2873
1.54
10.82
4.3
2.7
375.55
371.60
umol/l
0.26
353
2438
830
9454
0.66
10.78
6.1
5.7
6.69
6.16
mmol/l
15.44
744
8528
229
3352
0.62
9.94
2.7
3.0
0.78
0.75
ug/l
0.21
151
2338
31
88
3.58
9.53
3.9
2.6
58.04
60.33
%
0.21
26
70
34
104
3.33
9.34
1.2
1.2
—
—
—
0
0
59
246
2.46
9.24
1.8
1.4
—
—
—
0
0
140
815
1.80
9.08
8.0
6.5
23.22
24.59
mmol/l
3.10
130
787
533
4234
1.44
9.01
4.3
3.1
212.01
147.41
ug/l
4.07
499
3889
786
8943
0.70
8.95
5.4
4.7
1.45
1.29
mmol/l
6.13
701
8090
59
255
2.38
8.56
1.7
1.5
—
—
—
0
0
13
9
14.57
8.21
1.3
1.1
—
—
—
0
0
831
9305
0.71
8.02
10.4
7.5
43.90
40.81
mmol/mol
11.15
758
8624
130
774
1.75
7.81
1.8
1.7
—
—
—
0
0
12
8
15.12
7.72
2.1
1.0
—
—
—
0
0
473
5776
0.72
7.52
4.5
4.4
2.10
2.15
ug/l
0.10
396
5201
283
2054
1.48
7.44
2.8
1.7
2.90
1.41
mg/l
4.12
236
1628
784
8822
0.72
7.38
5.2
4.8
2.54
2.03
mu/l
6.11
701
7972
41
167
2.50
6.81
1.8
1.5
—
—
—
0
0
102
592
1.78
6.70
1.9
1.6
1.34
1.49
g/l
0.89
83
503
173
1155
1.57
6.67
3.5
2.0
80.73
67.70
e9/l
2.95
132
858
16
25
6.47
6.64
2.8
2.2
2.31
1.66
%
0.24
16
25
10
7
14.38
6.40
1.0
1.0
—
—
—
0
0
34
132
2.62
6.24
1.9
1.4
24760.57
83622.37
e6/l
0.62
21
75
32
122
2.66
6.09
1.8
1.5
—
—
—
0
0
68
358
1.95
6.07
1.3
1.3
—
—
—
0
0
47
215
2.23
6.06
1.8
1.3
—
—
—
0
0
36
148
2.47
5.90
2.0
1.4
1509.19
1371.60
e6/l
0.07
27
103
25
88
2.88
5.53
1.0
1.2
—
—
—
0
0
50
245
2.08
5.46
9.2
5.8
105.53
105.19
mmol/l
0.22
43
226
23
78
2.98
5.43
1.3
1.1
—
—
—
0
0
624
7117
0.76
5.41
4.5
3.7
14.72
15.04
pmol/l
2.49
556
6382
125
817
1.59
5.28
3.8
4.0
88.35
97.03
ng/l
0.74
112
684
16
35
4.62
5.18
2.8
2.6
—
—
—
0
0
48
238
2.06
5.10
1.4
1.2
—
—
—
0
0
502
4225
1.31
5.04
4.9
4.3
13.93
7.98
mg/mmol
1.77
359
2776
93
573
1.67
4.99
6.8
4.2
1.67
1.68
%
0.04
86
550
161
1127
1.49
4.99
3.2
3.3
225.76
262.71
ng/l
0.64
150
1054
55
289
1.94
4.98
3.9
3.5
1.87
1.49
index
0.21
38
146
834
9109
0.77
4.91
43.1
16.4
74.88
73.57
ml/min/173m2
0.90
794
8432
7
5
14.06
4.58
1.7
5.6
1660.40
278.80
u/l
—
7
5
46
238
1.97
4.39
1.4
1.6
—
—
—
0
0
60
339
1.81
4.39
2.1
2.2
194.07
103.35
ug/min
0.41
35
207
29
125
2.35
4.36
1.8
1.5
—
—
—
0
0
125
855
1.51
4.34
4.2
4.0
4.87
5.20
kpa
5.01
115
815
38
184
2.10
4.34
1.7
1.3
—
—
—
0
0
37
178
2.11
4.30
1.4
1.4
11.29
6.88
u/l
0.96
26
143
967
10300
0.76
4.23
62.7
24.9
123.10
136.02
g/l
87.16
942
10117
967
10299
0.76
4.22
64.4
25.2
37.16
40.45
%
61.12
941
10107
967
10299
0.76
4.22
62.1
24.7
4.15
4.48
e12/l
51.16
932
9944
31
140
2.24
4.20
2.4
2.2
106.58
105.49
mmol/l
0.76
31
140
31
140
2.24
4.20
2.4
2.2
4.37
4.13
mmol/l
1.38
31
140
967
10297
0.76
4.19
61.9
24.6
91.40
91.78
fl
1.32
942
10110
12
25
4.83
4.19
1.9
1.2
—
—
—
0
0
967
10296
0.76
4.18
62.2
24.7
206.28
233.75
e9/l
17.84
934
9991
105
1531
0.66
4.11
1.2
1.3
64.29
37.81
iu/ml
0.39
36
434
43
223
1.96
4.10
1.7
1.5
—
—
—
0
0
68
408
1.70
4.07
2.1
1.4
36.99
35.38
mg/l
0.18
52
347
30
136
2.23
4.04
2.4
2.2
1.19
1.18
mmol/l
0.38
30
136
490
4203
1.27
4.00
4.1
3.5
7.13
7.72
mmol/l
2.86
408
3543
68
410
1.69
4.00
2.1
1.4
51.80
46.09
mg/l
0.44
52
349
99
1438
0.66
3.80
1.2
1.2
22.64
16.45
u/ml
0.24
34
508
24
102
2.38
3.75
1.8
2.4
815.14
628.98
ml
0.99
14
61
61
365
1.70
3.71
2.1
1.4
1.56
1.44
ratio
0.31
33
217
59
350
1.72
3.70
1.8
1.4
0.00
0.00
g/l
-0.00
45
315
963
10216
0.78
3.66
54.7
22.3
89.46
86.71
umol/l
1.02
941
10049
23
97
2.40
3.66
3.2
3.3
24.59
12.62
index
1.01
17
50
18
68
2.67
3.57
1.8
1.7
11.83
15.19
umol/l
1.31
18
58
36
187
1.95
3.46
1.9
1.3
—
—
—
0
0
76
491
1.58
3.45
1.9
1.4
7.70
7.44
g/l
0.52
64
437
60
366
1.67
3.42
1.8
1.4
0.11
0.00
g/l
0.75
47
334
519
4547
1.23
3.37
4.8
4.4
40.32
87.51
ng/l
2.25
439
3601
105
733
1.47
3.34
4.1
3.8
1.64
2.01
mmol/l
0.43
67
525
291
2394
1.28
3.26
4.6
4.4
313.49
469.50
ng/l
0.61
255
2097
75
490
1.56
3.26
1.9
1.4
4.21
3.77
g/l
1.65
64
437
75
491
1.56
3.23
1.9
1.4
4.38
4.13
g/l
1.40
64
438
71
459
1.58
3.23
1.9
1.4
3.05
2.99
g/l
0.20
59
406
55
334
1.68
3.21
1.9
1.4
0.00
0.00
g/l
-0.00
44
314
66
426
1.58
3.04
1.8
1.4
0.68
0.46
g/l
0.23
50
367
277
2284
1.27
3.03
1.9
1.8
1171.90
1157.76
nmol/l
0.09
211
1738
19
81
2.37
2.99
2.1
1.6
—
—
—
0
0
19
81
2.37
2.99
1.9
1.5
—
—
—
0
0
14
52
2.71
2.89
1.7
1.4
—
—
—
0
0
31
164
1.91
2.87
1.8
1.3
—
—
—
0
0
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
57
362
1.60
2.82
1.5
1.9
46.35
38.67
u/l
1.28
48
300
61
394
1.58
2.82
2.1
2.9
—
—
—
0
0
20
91
2.22
2.74
1.5
1.3
—
—
—
0
0
21
98
2.16
2.71
1.5
1.3
—
—
—
0
0
66
439
1.53
2.69
1.8
1.4
12.50
10.46
g/l
1.61
52
382
44
266
1.68
2.65
1.4
1.4
—
—
—
0
0
44
266
1.68
2.65
1.4
1.4
—
—
—
0
0
126
951
1.36
2.63
3.1
2.4
212.90
165.24
ug/g
0.66
102
761
23
113
2.05
2.62
1.2
1.2
1.38
2.15
u/ml
0.68
13
41
18
81
2.24
2.54
1.3
1.2
—
—
—
0
0
18
81
2.24
2.54
1.3
1.2
—
—
—
0
0
18
81
2.24
2.54
1.3
1.2
—
—
—
0
0
13
50
2.62
2.53
1.4
1.3
—
—
—
0
0
14
56
2.52
2.53
1.7
1.3
—
—
—
0
0
953
10004
0.82
2.45
36.3
10.7
44.07
25.87
u/l
45.03
932
9602
13
51
2.56
2.44
1.6
1.5
—
—
—
0
0
13
51
2.56
2.44
1.4
1.3
—
—
—
0
0
13
51
2.56
2.44
1.6
1.5
—
—
—
0
0
16
70
2.30
2.41
1.4
1.3
17.13
14.75
u/l
0.55
16
65
19
90
2.13
2.39
1.2
1.3
—
—
—
0
0
11
39
2.84
2.34
1.0
1.1
1696.00
1576.67
miu/ml
0.12
11
39
19
94
2.04
2.16
2.3
2.1
—
—
—
0
0
14
61
2.31
2.15
1.7
1.3
—
—
—
0
0
22
116
1.91
2.11
1.3
1.2
2.47
8.00
u/ml
0.97
15
56
723
7730
0.85
2.10
54.7
21.9
330.93
332.53
g/l
4.36
713
7677
11
43
2.57
2.08
1.3
1.1
—
—
—
0
0
11
43
2.57
2.08
1.3
1.1
—
—
—
0
0
11
43
2.57
2.08
1.3
1.1
—
—
—
0
0
11
43
2.57
2.08
1.3
1.1
—
—
—
0
0
963
10053
0.84
2.05
50.9
21.4
4.05
4.02
mmol/l
1.64
938
9814
6
15
4.01
2.04
2.8
1.3
103.50
105.53
%
—
6
15
8
27
2.97
1.93
1.4
1.1
—
—
—
0
0
8
27
2.97
1.93
1.4
1.1
—
—
—
0
0
8
27
2.97
1.93
1.4
1.1
—
—
—
0
0
963
10036
0.85
1.91
50.8
21.2
137.73
139.78
mmol/l
68.43
941
9809
29
173
1.69
1.90
6.3
4.1
11.77
12.04
pmol/l
0.03
29
173
308
3501
0.84
1.89
1.9
1.8
17.41
19.44
nmol/l
1.97
276
2934
453
4088
1.17
1.88
3.3
3.4
1425.21
1755.26
ng/l
0.76
400
3573
0
53
0.00
1.87
0.0
4.5
—
13.42
—
0
53
23
129
1.80
1.86
1.2
1.2
2.19
1.48
nmol/l
1.41
23
113
64
460
1.41
1.85
1.8
1.7
—
—
—
0
0
6
17
3.54
1.84
1.2
1.0
—
—
—
0
0
18
321
0.55
1.73
1.3
1.5
27307.30
16364.43
e6/l
—
10
230
11
48
2.30
1.70
1.5
1.3
75.20
58.93
umol/l
—
5
30
59
427
1.40
1.67
1.7
1.6
—
—
—
0
0
425
4672
0.87
1.67
2.9
2.4
—
—
—
0
0
10
40
2.51
1.66
1.8
2.1
51.65
47.60
ug/l
—
10
40
285
2502
1.18
1.65
1.8
1.8
445.32
23975024.39
pmol/l
1.70
230
2048
7
25
2.81
1.65
1.4
1.2
15.64
9.33
ug/l
—
7
25
62
825
0.74
1.54
1.4
1.4
—
—
—
0
0
23
370
0.61
1.53
1.3
1.6
—
—
—
0
0
302
2681
1.16
1.52
4.7
3.4
0.00
0.00
estimate
0.80
104
827
0
43
0.00
1.52
0.0
1.0
—
—
—
0
0
17
93
1.84
1.52
1.5
1.2
—
—
—
0
0
122
997
1.25
1.49
3.1
2.3
0.52
0.54
e6/l
0.04
122
948
18
101
1.79
1.49
1.5
1.2
—
—
—
0
0
17
94
1.82
1.47
1.5
1.2
—
—
—
0
0
17
95
1.80
1.43
1.5
1.2
—
—
—
0
0
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
210
1828
1.18
1.36
1.3
1.3
1.43
1.42
u/ml
0.01
37
481
54
405
1.35
1.28
3.4
3.3
4.23
4.48
pmol/l
1.05
48
349
21
329
0.63
1.28
1.3
1.6
—
—
—
0
0
8
35
2.29
1.27
1.5
1.3
—
—
—
0
0
73
574
1.29
1.26
4.5
3.4
1.02
1.02
ratio
1.23
67
528
17
100
1.71
1.23
1.5
1.2
—
—
—
0
0
26
172
1.52
1.21
8.5
6.9
9.62
7.58
mmol/l
1.32
21
146
17
101
1.69
1.20
1.5
1.2
—
—
—
0
0
112
1333
0.83
1.16
4.4
5.4
32.78
32.51
%
0.09
82
841
22
330
0.66
1.13
1.1
1.1
—
—
—
0
0
57
441
1.31
1.13
4.6
4.4
23.91
24.79
mmol/l
1.44
51
400
7
34
2.06
1.03
1.7
1.4
—
—
—
0
0
7
34
2.06
1.03
1.7
1.4
—
—
—
0
0
35
256
1.38
1.01
1.2
1.1
—
—
—
0
0
139
1204
1.17
0.99
2.5
2.5
6.48
8.16
ug/l
0.60
118
1052
27
191
1.42
0.95
1.3
1.3
—
—
—
0
0
34
253
1.35
0.91
1.2
1.1
—
—
—
0
0
17
111
1.54
0.88
1.2
1.1
—
—
—
0
0
10
56
1.79
0.88
1.0
1.0
—
—
—
0
0
8
44
1.82
0.86
1.8
1.2
—
—
—
0
0
329
3047
1.11
0.86
5.2
3.9
0.00
0.00
estimate
0.50
107
944
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
14
88
1.60
0.84
1.1
1.1
91.71
94.53
%
0.15
14
83
12
73
1.65
0.81
1.1
1.1
—
—
—
0
0
41
320
1.29
0.81
2.5
2.2
116.29
132.17
g/l
3.91
31
254
21
147
1.44
0.80
2.0
2.3
12.83
17.59
mg/l
—
6
48
0
24
0.00
0.79
0.0
1.4
—
15.61
—
0
16
0
27
0.00
0.77
0.0
1.1
—
1.06
—
0
19
5
100
0.50
0.77
1.0
1.2
7.12
7.45
mmol/l
—
5
87
13
83
1.57
0.75
1.1
1.1
—
—
—
0
0
424
4000
1.09
0.74
5.0
3.8
0.22
0.02
estimate
0.45
116
880
16
108
1.49
0.73
1.3
1.1
100.75
109.28
%
0.38
16
98
80
928
0.85
0.69
2.5
2.3
12.40
15.33
nmol/l
1.87
68
824
12
77
1.56
0.68
1.1
1.1
—
—
—
0
0
12
77
1.56
0.68
1.1
1.1
—
—
—
0
0
7
117
0.60
0.68
1.1
1.1
—
66.44
—
0
9
15
102
1.48
0.67
1.5
1.4
18.31
24.71
iu/l
—
10
81
16
226
0.70
0.67
1.3
1.3
2.73
44.83
e6/l
0.95
11
179
29
226
1.29
0.62
1.2
1.4
0.62
0.81
nmol/l
1.02
21
184
5
30
1.67
0.61
1.4
1.1
—
—
—
0
0
21
278
0.75
0.61
1.1
1.2
—
55.88
—
0
11
0
21
0.00
0.60
0.0
1.3
—
13.51
—
0
8
13
89
1.47
0.58
1.2
1.1
—
—
—
0
0
559
5379
1.07
0.57
4.9
3.8
19.69
1.61
estimate
0.72
138
1089
551
5303
1.07
0.55
4.8
3.8
0.00
0.00
estimate
-0.00
132
1068
9
62
1.45
0.53
1.2
1.1
—
—
—
0
0
9
62
1.45
0.53
1.2
1.1
—
—
—
0
0
19
143
1.33
0.52
1.6
1.4
—
—
—
0
0
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
42
499
0.84
0.51
1.5
1.4
—
—
—
0
0
24
188
1.28
0.51
1.0
1.1
—
2.39
—
0
14
22
280
0.78
0.50
1.8
2.0
208.73
208.56
pmol/l
0.00
22
263
559
5404
1.06
0.48
4.9
3.8
8.26
0.02
estimate
0.50
122
998
5
81
0.62
0.46
1.0
1.0
—
—
—
0
0
5
82
0.61
0.46
1.2
1.3
114.60
106.96
pmol/l
—
5
82
5
32
1.56
0.42
1.4
1.1
—
—
—
0
0
5
32
1.56
0.42
13.2
6.8
6.54
5.23
kpa
—
5
32
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
14
107
1.31
0.37
1.1
1.1
—
25.21
—
0
19
27
321
0.84
0.36
2.9
3.4
0.85
0.82
nmol/l
0.15
22
263
6
42
1.43
0.35
1.7
1.1
690.83
237.85
iu/ml
—
6
42
38
329
1.16
0.35
1.2
1.2
—
—
—
0
0
6
43
1.40
0.35
1.0
2.3
1955.83
824.05
u/ml
—
6
43
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.0
1.2
—
—
—
0
0
6
47
1.28
0.32
1.2
1.4
0.83
3.56
u/field
—
6
32
7
98
0.71
0.31
1.1
1.4
—
—
—
0
0
130
1381
0.93
0.29
14.6
7.3
—
—
—
0
0
240
2500
0.95
0.28
5.4
4.0
1.02
1.02
kg/l
0.69
174
1655
11
140
0.78
0.28
1.1
1.1
—
5.17
—
0
6
16
131
1.22
0.27
1.3
1.4
1.64
14.26
nmol/l
0.45
16
125
5
73
0.68
0.26
2.6
2.8
26.00
33.41
mg/l
—
5
58
959
9487
1.04
0.25
42.9
16.6
34.28
27.35
mg/l
8.32
931
7855
11
87
1.27
0.24
2.4
1.4
9.43
7.80
mmol/l
0.58
11
87
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
38.44
38.82
g/l
—
5
39
0
11
0.00
0.21
0.0
1.3
—
6.06
—
0
11
0
11
0.00
0.21
0.0
1.0
—
33.85
—
0
11
0
11
0.00
0.21
0.0
1.2
—
72.75
—
0
5
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
101
956
1.06
0.20
1.3
1.4
—
—
—
0
0
16
187
0.85
0.20
1.1
1.2
—
59.94
—
0
17
0
14
0.00
0.20
0.0
1.4
—
0.89
—
0
9
0
14
0.00
0.20
0.0
1.4
—
1.05
—
0
9
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
1.18
—
0
9
30
334
0.90
0.20
1.3
1.4
—
—
—
0
0
9
114
0.79
0.20
1.2
1.0
—
—
—
0
0
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
5
70
0.71
0.16
3.2
1.6
73.20
93.27
umol/l
—
5
70
7
87
0.80
0.14
1.1
1.4
—
—
—
0
0
11
93
1.18
0.14
1.0
1.2
—
1.94
—
0
10
13
113
1.15
0.13
1.0
1.0
—
—
—
0
0
441
4349
1.02
0.12
3.2
2.4
75.54
77.55
nmol/l
0.69
404
3802
24
259
0.93
0.10
1.5
1.7
—
—
—
0
0
515
5199
0.98
0.09
2.2
2.3
87.33
92.72
pmol/l
1.80
279
2842
28
262
1.07
0.09
1.4
1.5
2.22
0.12
iu/ml
—
9
57
757
7618
0.98
0.09
55.6
20.1
15.25
13.74
%
82.80
747
7487
24
257
0.93
0.08
1.1
1.2
—
—
—
0
0
44
421
1.05
0.08
1.2
1.2
9.41
121.63
u/ml
—
10
160
6
73
0.82
0.07
1.8
1.1
1.93
2.37
mmol/l
—
6
67
14
129
1.09
0.05
3.7
4.3
—
—
—
0
0
11
100
1.10
0.05
1.0
1.4
—
249.33
—
0
15
37
380
0.97
0.03
1.2
1.7
6.39
6.84
iu/ml
—
8
81
369
3706
0.99
0.02
2.1
2.3
194.42
266.86
u/l
1.21
351
3481
732
7334
1.00
0.02
6.0
4.2
23.35
12.80
mm/h
28.18
667
6776
14
146
0.96
0.00
3.4
2.4
-0.38
0.24
mmol/l
0.16
14
140
31
309
1.00
0.00
1.6
1.6
29.35
20.40
u/ml
—
6
61
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
5
59
0.85
0.00
3.6
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
0.02
—
0
5
5
54
0.93
-0.00
5.2
3.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
59.20
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS – Malignant neoplasm of liver and intrahepatic bile ducts
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).